Unthinkable? Reports That AZ May Spin Off China Ops Amid Geopolitical Risks

Competing Pressures, Deeper Localization

 
• By Brian Yang
  
China New Drug Approvals 2020
AZ reportedly to spin off its China subsidiary amid competing pressure, geoplitican tension • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia